Characterization of the potent gonadotropin-releasing activity of RF9, a selective antagonist of RF-amide-related peptides and neuropeptide FF receptors: physiological and pharmacological implications.
about
Kisspeptin Regulation of Neuronal Activity throughout the Central Nervous SystemDissecting the Roles of Gonadotropin-Inhibitory Hormone in Mammals: Studies Using Pharmacological Tools and Genetically Modified Mouse ModelsThe Role of Arginine-Phenylalanine-Amide-Related Peptides in Mammalian ReproductionNeurobiological study of fish brains gives insights into the nature of gonadotropin-releasing hormone 1-3 neuronsKnockdown of hypothalamic RFRP3 prevents chronic stress-induced infertility and embryo resorption.Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands.The roles of RFamide-related peptide-3 in mammalian reproductive function and behaviour.Gonadotropin-inhibitory hormone action in the brain and pituitaryThe lipophilic bullet hits the targets: medicinal chemistry of adamantane derivativesNeuropeptides in the gonads: from evolution to pharmacologyCircadian regulation of kisspeptin in female reproductive functioning.Development, sex steroid regulation, and phenotypic characterization of RFamide-related peptide (Rfrp) gene expression and RFamide receptors in the mouse hypothalamusCircadian control of neuroendocrine circuits regulating female reproductive functionGonadotropin-inhibitory hormone (GnIH): discovery, progress and prospect.The role of kisspeptin and RFamide-related peptide-3 neurones in the circadian-timed preovulatory luteinising hormone surge.RF9 Acts as a KISS1R Agonist In Vivo and In Vitro.Direct Actions of Kisspeptins on GnRH Neurons Permit Attainment of Fertility but are Insufficient to Fully Preserve Gonadotropic Axis Activity.Review: regulatory mechanisms of gonadotropin-inhibitory hormone (GnIH) synthesis and release in photoperiodic animalsRole of neuropeptide FF in central cardiovascular and neuroendocrine regulation.What's in a Name? Roles of RFamide-Related Peptides Beyond Gonadotrophin Inhibition.The Inhibitory Effects of RFamide-Related Peptide 3 on Luteinizing Hormone Release Involves an Estradiol-Dependent Manner in Prepubertal but Not in Adult Female Mice.Hypothalamic distribution, adenohypophyseal receptor expression, and ligand functionality of RFamide-related peptide 3 in the mare during the breeding and nonbreeding seasons.Characterization of the inhibitory roles of RFRP3, the mammalian ortholog of GnIH, in the control of gonadotropin secretion in the rat: in vivo and in vitro studies.Relationship of neuropeptide FF receptors with pubertal maturation of gilts.Analysis on DNA sequence of goat RFRP gene and its possible association with average daily sunshine duration.Is precocious puberty linked to hypothalamic expression of arginine-phenylalanine-amide-related peptide?RF9 powerfully stimulates gonadotrophin secretion in the ewe: evidence for a seasonal threshold of sensitivity.Editorial: The Roles of GnIH in Reproductive Function and Behavior.Comparative and Evolutionary Aspects of Gonadotropin-Inhibitory Hormone and FMRFamide-Like Peptide Systems
P2860
Q26744425-F57CDE97-3111-40B1-B6C6-1A944916E4F3Q26771477-68D332E2-9683-4733-BCC0-8935D23C99CEQ26773640-468C9BCE-FEC9-4429-8C33-B806AE151C56Q27004128-00F570EF-5E0D-4BB1-8534-880C0374C775Q30408428-DC5D0316-D930-4B73-8406-1462FE740297Q33598685-76A4E3E8-ECD5-4C5C-9331-7A997D624321Q34015369-84F4C31B-FA94-4052-B61C-FD5D9D8F3F85Q34317149-F541F416-AC2E-49BE-AAF4-CFBFA507D77EQ34329204-23B1F8A6-1B08-44B4-A689-EFCFD724404CQ34983567-EB6B646B-FB31-4E52-A0E6-905F7D711B74Q35272978-B4171B90-A3D9-42EA-99B1-604CE022649FQ35872721-02152DE9-32B0-4228-8321-2BC0F719ED6BQ35974794-CB357DC0-509B-4448-9B67-DF465A0053A7Q36044550-CC07434F-4A09-48AE-91CF-09CBD6CABC4FQ36062826-DAA2D047-6497-4911-82E5-65FF75283440Q36305133-E501074D-C6E3-4CAC-A44B-F84E046179A2Q36453894-7B18C774-F6B9-4A5D-ADEF-9918833894AFQ36768024-ED76BD4E-C316-401B-9F45-21220B0DFFC0Q38081115-56403F96-16FE-4726-99F6-A8F599F21D21Q38883710-4600499C-CE17-4496-8E65-3D0223721C33Q40847164-14FF9FFC-9C18-4D3F-8F5A-AA00B4E24E4AQ42451870-F5E6BBFA-80C0-499C-A327-7970B8FC8852Q42470776-A0891C40-19FF-435F-9B2A-7343D4DD6B6CQ45055575-BAC4112D-BBDA-4ABD-9D71-8E874B73701DQ45405516-B8243D9E-372B-4576-AEF0-8847987AB246Q47141569-D6821A1D-E415-413E-82B4-13DC8F609ED6Q48689888-78CA1E4C-F3BC-4D3C-8567-64B01ACBEFF5Q49709976-13C8CDC5-2732-421E-9612-02B5439F38FAQ58596274-251636BC-2804-4C76-A484-0AC35EEDA025
P2860
Characterization of the potent gonadotropin-releasing activity of RF9, a selective antagonist of RF-amide-related peptides and neuropeptide FF receptors: physiological and pharmacological implications.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Characterization of the potent ...... pharmacological implications.
@ast
Characterization of the potent ...... pharmacological implications.
@en
Characterization of the potent ...... pharmacological implications.
@nl
type
label
Characterization of the potent ...... pharmacological implications.
@ast
Characterization of the potent ...... pharmacological implications.
@en
Characterization of the potent ...... pharmacological implications.
@nl
prefLabel
Characterization of the potent ...... pharmacological implications.
@ast
Characterization of the potent ...... pharmacological implications.
@en
Characterization of the potent ...... pharmacological implications.
@nl
P2093
P356
P1433
P1476
Characterization of the potent ...... pharmacological implications.
@en
P2093
D Garcia-Galiano
F A Dijcks
F Ruiz-Pino
M A Sanchez-Garrido
M Blomenröhr
M Tena-Sempere
P I van Noort
P304
P356
10.1210/EN.2009-1259
P407
P577
2010-02-16T00:00:00Z